Advertisement
Screener

SpyGlass Pharma, Inc. (SGP) Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

SpyGlass Pharma, Inc. Current Liabilities

SpyGlass Pharma, Inc. (SGP) had Current Liabilities of $9.44 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:LiabilitiesCurrent · last filed 2026-08-06

  • 2026-06-30: Liabilities, Current $9.44M.
  • 2026-03-31: Liabilities, Current $6.67M.
  • 2025-12-31: Liabilities, Current $8.58M.
  • 2024-12-31: Liabilities, Current $7.79M.
Period endLiabilities, Current
2026-06-30$9.44M
10-Q · filed 2026-08-06
2026-03-31$6.67M
10-Q · filed 2026-05-14
2025-12-31$8.58M
10-Q · filed 2026-08-06
2024-12-31$7.79M
10-K · filed 2026-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B